LianBio operates as a biopharmaceutical company, which engages in the development and commercialization of medicines for patients with unmet medical needs. The company is headquartered in Princeton, New Jersey and currently employs 163 full-time employees. The company went IPO on 2021-10-28. The firm is also pursuing the sale of its remaining pipeline assets.
Financials in millions USD. Fiscal year is February - January.
Breakdown
TTM
09/30/2023
06/30/2023
03/31/2023
12/31/2022
09/30/2022
Revenue
0
0
0
0
0
0
Revenue Growth (YoY)
--
--
--
--
--
--
Cost of Revenue
--
--
--
--
--
--
Gross Profit
--
--
--
--
--
--
Selling, General & Admin
66
17
15
15
18
16
Research & Development
39
9
9
10
10
8
Operating Expenses
106
26
25
25
29
24
Other Non Operating Income (Expenses)
9
0
0
0
8
1
Pretax Income
-87
-23
-21
-23
-18
-21
Income Tax Expense
0
0
0
0
0
0
Net Income
-87
-24
-21
-24
-18
-21
Net Income Growth
-23%
14%
-50%
-11%
-14%
62%
Shares Outstanding (Diluted)
107.17
107.17
107.16
107.16
108.13
108.35
Shares Change (YoY)
-1%
-1%
-1%
0%
3%
3%
EPS (Diluted)
-0.81
-0.22
-0.2
-0.22
-0.17
-0.2
EPS Growth
-23%
10%
-49%
-15%
-15%
67%
Free Cash Flow
-84
-16
-19
-17
-30
-16
Free Cash Flow Per Share
--
--
--
--
--
--
Gross Margin
--
--
--
--
--
--
Operating Margin
0%
0%
0%
0%
0%
0%
Profit Margin
0%
0%
0%
0%
0%
0%
Free Cash Flow Margin
0%
0%
0%
0%
0%
0%
EBITDA
-105
-26
-25
-25
-29
-24
EBITDA Margin
0%
0%
0%
0%
0%
0%
D&A For EBITDA
1
0
0
0
0
0
EBIT
-106
-26
-25
-25
-29
-24
EBIT Margin
0%
0%
0%
0%
0%
0%
Effective Tax Rate
0%
0%
0%
0%
0%
0%
Follow-Up Questions
What are LianBio's key financial statements?
According to the latest financial statement (Form-10K), LianBio has a total asset of $0, Net loss of $0
What are the key financial ratios for LIANY?
LianBio's Current ratio is 0, has a Net margin is 0, sales per share of $0.
How is LianBio's revenue broken down by segment or geography?
LianBio largest revenue segment is One-on-One Online English Language Education Services, at a revenue of 50,692,000 in the most earnings release.For geography, Asia-Pacific is the primary market for LianBio, at a revenue of 33,256,000.
Is LianBio profitable?
no, according to the latest financial statements, LianBio has a net loss of $0